In diabetes rats, GA treatment resulted in a dose-dependent decrease in blood glucose level, as evidenced by lowered AUCglucose, insulin levels, and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) indices (Abdel-Moneim et al., 2017; Variya et al., 2020). The gene discussed is INS; the disease is diabetes mellitus.